Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Novartis
Covington
Moodys
Chinese Patent Office
Daiichi Sankyo
Farmers Insurance
Johnson and Johnson
Dow
Colorcon

Generated: August 18, 2017

DrugPatentWatch Database Preview

Laboratorios Salvat Company Profile

« Back to Dashboard

What is the competitive landscape for LABORATORIOS SALVAT, and what generic alternatives to LABORATORIOS SALVAT drugs are available?

LABORATORIOS SALVAT has one approved drug.

There is one US patent protecting LABORATORIOS SALVAT drugs.

There are fourteen patent family members on LABORATORIOS SALVAT drugs in thirteen countries.

Summary for Applicant: Laboratorios Salvat

Patents:1
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Laboratorios Salvat
OTOVEL
ciprofloxacin hydrochloride; fluocinolone acetonide
SOLUTION/DROPS;OTIC208251-001Apr 29, 2016RXYesYes► Subscribe► Subscribe► Subscribe
Laboratorios Salvat
OTOVEL
ciprofloxacin hydrochloride; fluocinolone acetonide
SOLUTION/DROPS;OTIC208251-001Apr 29, 2016RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Laboratorios Salvat Drugs

Country Document Number Estimated Expiration
Australia2011223095► Subscribe
Spain2391721► Subscribe
Canada2790652► Subscribe
Russian Federation2012141641► Subscribe
European Patent Office2366408► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Laboratorios Salvat Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB12/058United Kingdom► SubscribePRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003
C0012France► SubscribePRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
UBS
Fuji
Daiichi Sankyo
McKinsey
Farmers Insurance
Federal Trade Commission
Fish and Richardson
Moodys
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot